A blueprint for investing in biotech

Brent Johnson of Santiago Capital has a controversial point of view: he believes both the dollar and gold will move higher. He also offers a bold prediction on the direction of U.S. stocks over the coming months. Plus, Frank breaks down a simple strategy for finding ideas in the volatile biotech space… and ensuring the reward is worth the risk.

This episode